Clinical Trial Update: High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating high-dose versus standard-dose influenza vaccine in adults after lung transplantation is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Transplantation

Drugs mentioned

• Influenza vaccine, high-dose (high-dose influenza vaccine)
• Influenza vaccine, standard-dose (standard-dose influenza vaccine)

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Immunization; Infection, Transplantation Infection | Phase 2 | Status: RECRUITING